CA1036937A - Pharmaceutical heparinoidic factor-containing composition and therapeutic use thereof - Google Patents
Pharmaceutical heparinoidic factor-containing composition and therapeutic use thereofInfo
- Publication number
- CA1036937A CA1036937A CA223,809A CA223809A CA1036937A CA 1036937 A CA1036937 A CA 1036937A CA 223809 A CA223809 A CA 223809A CA 1036937 A CA1036937 A CA 1036937A
- Authority
- CA
- Canada
- Prior art keywords
- heparinoidic
- factor
- sodium
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT50134/74A IT1062779B (it) | 1974-04-04 | 1974-04-04 | Composizione farmaceutica contenente un fattore eparinoidico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1036937A true CA1036937A (en) | 1978-08-22 |
Family
ID=11272333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA223,809A Expired CA1036937A (en) | 1974-04-04 | 1975-04-03 | Pharmaceutical heparinoidic factor-containing composition and therapeutic use thereof |
Country Status (8)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1069492B (it) * | 1976-10-13 | 1985-03-25 | Alfa Farmaceutici Spa | Composizione farmaceutica sommini stratrice per via orale contenente un fattore eparinoide sospeso in un veicolo oleoso costituito da triace tato di glicerina |
| IT1090703B (it) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | Perfezionamento nelle composizioni utili quali veicolo per farmaci |
| USRE35770E (en) * | 1978-11-06 | 1998-04-14 | Choay, S.A. | Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them |
| IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
| US4826827A (en) * | 1979-10-05 | 1989-05-02 | Choay S.A. | Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs |
| DE3323389A1 (de) * | 1983-06-29 | 1985-01-10 | B. Braun Melsungen Ag, 3508 Melsungen | Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden |
| US4766111A (en) * | 1985-10-31 | 1988-08-23 | Trustees Of Boston University | Lipids with plasmin inhibitory properties |
| US4673667A (en) * | 1985-10-31 | 1987-06-16 | Trustees Of Boston University | Lipids with plasmin inhibitory properties |
| IT1245761B (it) * | 1991-01-30 | 1994-10-14 | Alfa Wassermann Spa | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
| CN103965664B (zh) * | 2013-01-25 | 2015-07-22 | 中国石油化工股份有限公司 | 一种碳黑粒子分散剂及其制备方法和应用 |
| CN113045855A (zh) * | 2021-05-10 | 2021-06-29 | 中山大学孙逸仙纪念医院 | 一种用于阻断卵巢性索间质肿瘤扩散的薄膜材料及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2661315A (en) * | 1947-12-19 | 1953-12-01 | Olin Mathieson | Prolonged-effectiveness injectable therapeutic preparation |
| US3000787A (en) * | 1957-11-06 | 1961-09-19 | Crinos Industria Farmaco | Heparinoid anticholestrolemic factor |
| US3574831A (en) * | 1968-05-29 | 1971-04-13 | American Cyanamid Co | Therapeutic heparin-sodium taurocholate compositions |
-
1974
- 1974-04-04 IT IT50134/74A patent/IT1062779B/it active
-
1975
- 1975-03-26 US US05/562,216 patent/US3985871A/en not_active Expired - Lifetime
- 1975-03-30 IL IL46965A patent/IL46965A/xx unknown
- 1975-04-01 FR FR7510129A patent/FR2266512B1/fr not_active Expired
- 1975-04-02 GB GB1352975A patent/GB1454244A/en not_active Expired
- 1975-04-02 DE DE2514335A patent/DE2514335C3/de not_active Expired
- 1975-04-03 CA CA223,809A patent/CA1036937A/en not_active Expired
- 1975-04-04 BE BE155121A patent/BE827595A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2514335A1 (de) | 1975-10-09 |
| IL46965A0 (en) | 1975-05-22 |
| IT1062779B (it) | 1985-01-14 |
| US3985871A (en) | 1976-10-12 |
| AU7980075A (en) | 1976-10-07 |
| IL46965A (en) | 1978-07-31 |
| BE827595A (fr) | 1975-07-31 |
| DE2514335C3 (de) | 1980-08-14 |
| DE2514335B2 (de) | 1979-12-06 |
| FR2266512A1 (US06826419-20041130-M00005.png) | 1975-10-31 |
| GB1454244A (en) | 1976-11-03 |
| FR2266512B1 (US06826419-20041130-M00005.png) | 1978-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7776881B2 (en) | Hyperlipemia therapeutic agent | |
| JPH09505809A (ja) | ヒドロキシカルバゾール化合物類による平滑筋移動および増殖の阻害 | |
| JP2568962B2 (ja) | 眼炎症処置用組成物 | |
| CA2059865C (en) | Pharmaceutical compositions containing orally absorbable glycosaminoglycans | |
| AU682029B2 (en) | Prodrugs with enhanced penetration into cells | |
| CA1036937A (en) | Pharmaceutical heparinoidic factor-containing composition and therapeutic use thereof | |
| US20050020665A1 (en) | Pharmaceutical composition for treating multiple sclerosis | |
| SK10802001A3 (sk) | Esenciálne mastné kyseliny na prevenciu kardiovaskulárnych príhod | |
| JPH0552814B2 (US06826419-20041130-M00005.png) | ||
| KR940000008B1 (ko) | 고지질혈증 치료용의 약학 조성물 | |
| IE58130B1 (en) | Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation | |
| JPH0696534B2 (ja) | 抗痴呆剤 | |
| NO324796B1 (no) | Anvendelse av fosfolipidkomplekser ekstrahert fra Vitis vinifera ved fremstilling av antiaterosklerotiske midler. | |
| JPH0142246B2 (US06826419-20041130-M00005.png) | ||
| JPH10513186A (ja) | Ｈｉｖプロテアーゼ阻害剤インジナビル及び逆転写酵素阻害剤３ｔｃを必要に応じてａｚｔ、ｄｄｉ、又はｄｄｃと共に用いるｈｉｖ感染の組合せ治療 | |
| JP2020516622A (ja) | ゲムカベン、薬学的に許容されるその塩、その組成物、およびその使用方法 | |
| CA1297100C (en) | Medicament for curing arteriosclerosis, comprising pyrimido [2,1-b]-benxothiazole derivative | |
| US4788200A (en) | Method and composition for treating arteriosclerosis | |
| WO2001068099A1 (en) | Modulation of cardiovascular injury | |
| JPS6245525A (ja) | 脂質低下剤 | |
| JP3186365B2 (ja) | 肝疾患治療薬 | |
| US6884818B1 (en) | Pharmaceutical compositions containing 8-chloro-3 (β-diethylaminoethyl)-4-methyl-7-ethoxycarbonylmethoxy coumarin base and the salts thereof with cholesterol-lowering activity | |
| EP0115331B1 (en) | Medicament for cerebral apoplexy | |
| US4199585A (en) | Method and composition for the therapy of cerebral circulatory diseases | |
| CA2353727C (en) | Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations |
